![](/img/cover-not-exists.png)
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
Joan C Egrie, Erik Dwyer, Jeffrey K Browne, Anna Hitz, Michele A LykosVolume:
31
Year:
2003
Language:
english
Pages:
10
DOI:
10.1016/s0301-472x(03)00006-7
File:
PDF, 232 KB
english, 2003